Skip to content
MarketScale
‹ Back to IndustriesHealthcare

TPC Talks: Navigating the Supply Chain Impact of COVID-19

There isn’t an industry that’s been hit harder by the tidal wave left in the wake of the spread of COVID-19 than healthcare. In particular, the healthcare supply chain has been disrupted in unprecedented ways, forcing hospitals to search for alternative solutions for sourcing key personal protective equipment, or PPE, among other vital patient care…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

There isn’t an industry that’s been hit harder by the tidal wave left in the wake of the spread of COVID-19 than healthcare.

In particular, the healthcare supply chain has been disrupted in unprecedented ways, forcing hospitals to search for alternative solutions for sourcing key personal protective equipment, or PPE, among other vital patient care products.

On this episode of TPC Talks, TPC Senior Vice President of Sourcing and Operations Beau Moon joined host Tyler Kern to highlight how TPC is assisting its Member family during this uncertain period.

“We are in these unreal times,” Moon said. “It’s unprecedented, really. The supply chain is front and center… It’s a situation where there is high demand for supply needs for our healthcare systems, and there’s just a lack of supply.”

Moon said the shortage extends beyond PPE and the other top-of-mind protective equipment, adding that a shortage of pharmaceutical supplies, ventilators and more have created a “perfect storm.”

However, there are avenues forward.

To better assess Members’ specific supply needs, TPC has established virtual forums, created new methods for tracking anticipated caseloads and conducted information gathering surveys. Based on the information discovered, TPC investigated and thoroughly vetted alternative suppliers and worked to match them to individual Member’s needs.

Success stories – and lessons to be applied as the world strives for a new normal – are beginning to appear.

“I think good things can happen in bad situations. … When I think about some of the changes that will take place – the supply chain will need to transform, specifically in healthcare,” Moon said. “There’s so much data out there. There are new technologies out there. I think there are going to be innovations … and a concerted effort to come together and rethink the entire supply chain.”

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512